Product Information
ALENDRONATE SODIUM 35 MG TAB is a generic product labeled by Cipla USA Inc., priced at $0.2813 per EA under NDC 69097022376. Its NADAC has been published 569 times since Nov 11, 2015.
FDA first approved this application on Aug 4, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
35 mg/1
Manufacturer
Cipla USA Inc.NDC
69097022376
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ALENDRONATE SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA076768FDA Approved
8/4/2008
TE Code
AB
On Market Since
8/4/2008
Pharmacological Classes
Price Statistics
The NADAC for ALENDRONATE SODIUM 35 MG TAB has been published 569 times since Nov 11, 2015, and over the history we have for it it has declined 39.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2813 per EA |
|---|---|
| All-time high | $0.6790 (Apr 13, 2016) |
| All-time low | $0.2813 (Sep 23, 2026) |
| 52-week high | $0.3120 |
| 52-week low | $0.2813 |
| Median price | $0.3907 |
| Average price | $0.4076 |
| Largest weekly change | +22.2% (May 17, 2017) |
| Weeks tracked | 569 |
| Tracking since | Nov 11, 2015 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Alendronate sodium market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cipla USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Alendronate sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Bisphosphonate class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ALENDRONATE SODIUM 35 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for ALENDRONATE SODIUM 35 MG TAB, manufactured by Cipla USA Inc., is $0.2813 per EA (NDC 69097022376), effective Sep 30, 2026.
How has the price of ALENDRONATE SODIUM 35 MG TAB changed over time?
Over the history we have for it, the NADAC for ALENDRONATE SODIUM 35 MG TAB has declined 39.6%. It has been tracked across 569 weekly CMS publications since Nov 11, 2015.
What are the highest and lowest recorded NADAC prices for ALENDRONATE SODIUM 35 MG TAB?
Since Nov 11, 2015, the NADAC for ALENDRONATE SODIUM 35 MG TAB has ranged from a low of $0.2813 (Sep 23, 2026) to a high of $0.6790 (Apr 13, 2016), with a median of $0.3907 per EA.
Are there cheaper alternatives to ALENDRONATE SODIUM 35 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of ALENDRONATE SODIUM 35 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ALENDRONATE SODIUM 35 MG TAB?
ALENDRONATE SODIUM 35 MG TAB (NDC 69097022376) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.